TECHNOLOGY FUNDING SECURED INVESTORS III
10-K, 1995-03-20
FINANCE SERVICES
Previous: IDEX CORP /DE/, 10-K, 1995-03-20
Next: STAR FUNDS, 497, 1995-03-20



<PAGE>
                             UNITED STATES
                  SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C.  20549

                              FORM 10-K

[X]  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
     EXCHANGE ACT OF 1934

                 For The Year Ended December 31, 1994

                                    OR

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
     SECURITIES EXCHANGE ACT OF 1934

            For the transition period from N/A to N/A
                                           ---    ---

                      Commission File No. 0-19221

                TECHNOLOGY FUNDING SECURED INVESTORS III,
                 AN INCOME AND GROWTH PARTNERSHIP, L.P.
          ------------------------------------------------------
          (Exact name of Registrant as specified in its charter)

          CALIFORNIA                            94-3081010
- -------------------------------    ----------------------------------
(State or other jurisdiction of   (I.R.S. Employer Identification No.)
incorporation or organization) 

2000 Alameda de las Pulgas, Suite 250
San Mateo, California                                            94403
- ---------------------------------------                       --------
(Address of principal executive offices)                    (Zip Code)

                              (415) 345-2200
             --------------------------------------------------
            (Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:  None
Securities registered pursuant to Section 12(g) of the Act:  Limited
 Partnership Units

Indicate by check mark whether the Registrant (1) has filed all 
reports required to be filed by Section 13 or 15(d) of the Securities 
Exchange Act of 1934 during the preceding 12 months (or for such 
shorter period that the Registrant was required to file such reports), 
and (2) has been subject to such filing requirements for the past 90 
days.                                                    Yes X  No   
                                                            ---   ---

Indicate by check mark if disclosure of delinquent filers pursuant to 
Item 405 of Regulation S-K is not contained herein, and will not be 
contained, to the best of registrant's knowledge, in definitive proxy 
or information statements incorporated by reference in Part III of 
this Form 10-K or any amendment to this Form 10-K.          [   ]

No resale market for the units of limited partnership interests 
("Units") exists, and therefore the market value of such Units cannot 
be determined.

Documents incorporated by reference:  Portions of the Prospectus dated 
March 16, 1989 forming a part of Registration Statement No. 33-26190 
are incorporated by reference in Parts I and III hereof.  Portions of 
the Prospectus of Technology Funding Medical Partners I, L.P., as 
modified by Cumulative Supplement No. 4 dated January 4, 1995, forming 
a part of the May 3, 1993 Pre-Effective Amendment No. 3 to the Form N-
2 Registration Statement No. 33-54002 dated October 30, 1992 which is 
incorporated by reference in Part III hereof.

<PAGE>
                                PART I

Item 1.  BUSINESS
- ------   --------

Technology Funding Secured Investors III, An Income and 
Growth Partnership, L.P. (hereinafter referred to as the 
"Partnership" or the "Registrant") was formed as a California 
limited partnership on December 9, 1988.  The business of the 
Partnership is to provide loans secured by equipment and 
other assets to new and developing companies and to acquire 
equity interests in these companies as described in the 
"Summary of the Offering" and "Business of the Partnership" 
sections of the Prospectus dated March 16, 1989 that forms a 
part of Registrant's Form S-1 Registration Statement No. 33-
26190 (such Prospectus, as supplemented, is hereinafter 
referred to as the "Prospectus"), which sections are 
incorporated herein by reference.  Additional characteristics 
of the Partnership's business are discussed in the "Risk 
Factors" and "Conflicts of Interest" sections of the 
Prospectus, which sections are also incorporated herein by 
reference.  The Partnership's Amended and Restated Limited 
Partnership Agreement ("Partnership Agreement") provides that 
the Partnership will continue until December 31, 1998, unless 
further extended for up to two additional two-year periods 
from such date if the General Partners so determine or the 
Partnership may be dissolved sooner.

Item 2.  PROPERTIES
- ------   ----------

The Registrant has no material physical properties.

Item 3.  LEGAL PROCEEDINGS
- ------   -----------------

There are no material pending legal proceedings to which the 
Registrant is party or of which any of its property is the 
subject, other than ordinary routine litigation incidental to 
the business of the Partnership.

Item 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
- ------   ---------------------------------------------------

No matter was submitted to a vote of the holders of units of 
limited partnership interests ("Units") during 1994.

                               PART II

Item 5.  MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED   
- ------   -------------------------------------------------
         STOCKHOLDER MATTERS
         ----------- -------

(a)  There is no established public trading market for the 
Units.

(b)  At December 31, 1994, there were 5,179 record holders of 
Units.

(c)  The Registrant, being a partnership, does not pay 
dividends.  Cash distributions, however, may be made to 
the partners in the Partnership pursuant to the 
Registrant's Partnership Agreement.

Item 6.  SELECTED FINANCIAL DATA
- ------   -----------------------




<TABLE>
<CAPTION>
                                       For the Years Ended and as of December 31,
                              ----------------------------------------------------------------
<S>                           <C>           <C>          <C>          <C>          <C>
                                    1994       1993         1992         1991         1990
                                    ----       ----         ----         ----         ----

Total income                  $ 1,512,194    1,367,023    2,806,215    3,009,081    2,049,130
Net realized (loss) income     (3,087,046)  (1,112,972)     944,117    1,589,196     (786,051)
Change in net unrealized 
  fair value:
 Equity investments            (2,281,481)     209,851   (1,506,486)     987,225       15,268
 Secured notes receivable        (139,000)    (118,000)  (2,945,926)    (496,887)    (110,100)
Net (loss) income              (5,507,527)  (1,021,121)  (3,508,295)   2,079,534     (880,883)
Net realized (loss) income
 per Unit                              (8)          (3)           2            4           (2)
Total assets                   12,058,547   18,141,077   22,919,883   29,978,859   28,995,386
Distributions declared           (574,167)  (2,445,411)  (3,646,141)  (3,377,394)  (2,010,319)


</TABLE>




Refer to Notes 1 and 4 of the financial statements entitled 
"Summary of Significant Accounting Policies" and "Allocation 
of Profits and Losses" for a description of the method of 
calculation of net realized (loss) income per Unit.

Item 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
- ------   -----------------------------------------------------------
         AND RESULTS OF OPERATIONS
         -------------------------

         Liquidity and Capital Resources
         -------------------------------

In 1994, net cash used by operations totaled $28,480.  The 
Partnership paid management fees of $280,286 to the Managing 
General Partner, reimbursed related parties for operating 
expenses of $408,558 and received $40,179 in net loan 
participations to affiliated partnerships in 1994.  Other 
operating expenses of $504,228 were paid and $920,099 and 
$16,873 in interest and other income, respectively, were 
received.  In addition, the Partnership received a 
reimbursement from a portfolio company of $187,441 for 
collection expenses.  

In 1994, the Partnership issued $4,075,046 in secured notes 
receivable primarily to portfolio companies in the computers 
and computer equipment and medical industries.  Repayments of 
secured notes receivable provided cash of $3,147,801.  In 
addition, the Partnership purchased equity investments of 
$48,206 primarily in the microelectronics and 
telecommunications industries and received proceeds totaling 
$430,181.  As of December 31, 1994, the Partnership was 
committed to fund up to an additional $484,000 on accounts 
receivable lines of credit to existing borrowing companies.

The Partnership distributed $568,425 to Limited Partners and 
$5,742 to General Partners in 1994.  Future distributions 
will be dependent upon loan repayments from borrowing 
companies and available cash.

In February 1994, Alantec completed its initial public 
offering.  The Partnership simultaneously exercised its 
warrants without cash and sold the resulting common shares in 
the offering for total cash proceeds of $430,053.

All management fees which are due have been paid through 
December 31, 1994.  Management fees are paid to the extent 
that the aggregate amount of all proceeds (including those 
from warrants exercised without cash) received by the 
Partnership from the sale or other disposition of borrowing 
company equities, plus the aggregate fair market value of any 
equity securities distributed to the partners, exceeds the 
total management fee payable as defined in the Partnership 
Agreement.

Cash and cash equivalents at December 31, 1994 were 
$1,921,850.  Operating cash reserves combined with investment 
sale proceeds, interest income received on short-term 
investments and repayments of secured notes receivable are 
expected to be sufficient to fund Partnership operations and 
loan requirements of existing borrowing companies through the 
next twelve months.

Results of Operations
- ---------------------

1994 compared to 1993
- ---------------------

Net loss was $5,507,527 and $1,021,121 in 1994 and 1993, 
respectively.  The increase was primarily due to a $2,491,332 
decrease in the change in net unrealized fair value of equity 
investments, a $2,179,646 increase in realized losses from 
investment write-downs, and a $132,220 increase in other 
investment expenses.  These changes were partially offset by 
a $145,171 increase in total income and a $136,010 decrease 
in total operating expenses. 

The change in fair value of equity investments reflected a 
net decrease in the fair value of the Partnership's holdings.  
In 1994, the decrease of $2,281,481 was primarily due to a 
portfolio company in the medical industry.  In 1993, the 
increase was $209,851.  

In 1994 and 1993, the Partnership realized losses from 
investment write-downs of $4,082,445 and $1,902,799, 
respectively.  Realized losses in 1994 primarily related to 
secured notes receivable to a portfolio company in the 
computers and computer equipment industry.  Realized losses 
in 1993 primarily related to equity investments in a 
portfolio company in the retail/consumer products industry as 
well as the Partnership's loan portfolio for companies in the 
computers and computer equipment, and retail/consumer 
products industries.

During 1994, the Partnership recorded other investment 
expenses of $132,220 related to legal proceedings with a 
third party for a portfolio company in the retail/consumer 
products industry. The Managing General Partner is subject to 
indemnification for such costs pursuant to the Partnership 
Agreement.  See Note 9 to the financial statements for 
further details.  No such expenses were recorded in 1993.

Total income was $1,512,194 and $1,367,023 in 1994 and 1993, 
respectively.  The increase was primarily due to cash 
interest payments on a secured note receivable from a 
portfolio company in the computer software and systems 
industry which had been on nonaccrual status.  This increase 
was partially offset by a decrease in interest income due to 
the placement of secured notes receivable on nonaccrual 
status for portfolio companies in the medical and 
industrial/business automation industries.

Total operating expenses were $534,391 in 1994 compared to 
$670,401 in 1993.  As explained in Note 3 to the financial 
statements, the Partnership may not pay or reimburse the 
General Partners for annual expenses that aggregate more than 
a certain percentage of total limited partner capital 
contributions.  The limitation is calculated over an 
operating year beginning May 1.  In 1994 and 1993, the 
General Partners absorbed $95,227 and $268,515, respectively.  
Had the limitation not been in effect and the 1994 recoveries 
discussed in Note 3 to the financial statements not occurred, 
total operating expenses in 1994 and 1993 would have been 
$781,806 and $938,916, respectively.  The decrease in 
expenses was primarily due to lower lending operations and 
investment management, and administrative and investor 
services expenses as a result of lower overall portfolio 
activity.

The Partnership's portfolio of secured notes receivable is 
with new and developing companies; therefore, there is no 
established source of market value information.  The value of 
the portfolio has been estimated by the Managing General 
Partner in the absence of readily ascertainable market 
values.  Although secured notes receivable are secured by 
specific assets of the borrowing company, due to the inherent 
uncertainty of valuation, estimated values may differ 
significantly from the values that would have been used had a 
ready market for the investment existed.  The difference 
could be material.

Given the inherent risk associated with the business of the 
Partnership, the future performance of the portfolio company 
investments may significantly impact future operations.

1993 compared to 1992
- ---------------------

Net loss was $1,021,121 and $3,508,295 in 1993 and 1992, 
respectively.  The change was primarily due to increases of 
$2,827,926 and $1,716,337 in the change in net unrealized 
fair value of secured notes receivable and equity 
investments, respectively, a decrease of $520,711 in total 
operating expenses and an increase of $348,378 in net 
realized gain from sale of equity investments.  These changes 
were partially offset by a $1,626,515 increase in realized 
losses from investment write-downs and a $1,372,172 decrease 
in notes receivable interest income.

The Partnership recorded decreases in the change in fair 
value of secured notes receivable of $118,000 and $2,945,526 
in 1993 and 1992, respectively, based upon the level of loan 
loss reserves deemed adequate by the Managing General Partner 
at the respective year ends.  

The change in fair value of equity investments reflected a 
net increase in the fair value of the Partnership's holdings.  
In 1993, the increase was $209,851.  In 1992, the decrease of 
$1,506,486 was primarily due to portfolio companies in the 
retail/consumer products, telecommunications, and computer 
systems and software industries.

Total operating expenses were $670,401 in 1993 compared to 
$1,191,112 in 1992.  A major portion of the decrease was due 
to lower overall portfolio activity.  The remaining decrease 
was due to the 2% operating expense limitation.  As explained 
in Note 3 to the financial statements, the Partnership may 
not pay or reimburse the General Partners for annual expenses 
that aggregate more than 2% of total limited partner capital 
contributions; the excess absorbed totaled $268,515 and 
$77,452 in 1993 and 1992, respectively.  As the limitation is 
calculated over an operating year beginning May 1, the 
significant increase in expenses absorbed during 1993 was the 
result of an increase in Partnership expenses in late 1992.  
Had the limitation not been in effect, total operating 
expenses in 1993 and 1992 would have been $938,916 and 
$1,268,564, respectively.

Net realized gain on sale of equity investments were $476,335 
and $127,957 in 1993 and 1992, respectively.  The gain in 
1993 mainly related to investment sales in Cornerstone 
Imaging, Inc. and Software Transformation, Inc.  In 1992, the 
gain was primarily attributable to the net exercise of 
Videoconferencing Systems, Inc. warrants at their initial 
public offering.

In 1993 and 1992, the Partnership realized losses from 
investment write-downs of $1,902,799 and $276,284, 
respectively.  Realized losses in 1993 primarily related to 
equity investments in a portfolio company in the 
retail/consumer products industry as well as the 
Partnership's loan losses for portfolio companies in the 
computers and computer equipment, and retail/consumer 
products industries.  Realized losses in 1992 primarily 
related to secured notes receivable to portfolio companies in 
the retail/consumer products and medical industries.

Secured notes receivable interest income was $1,185,647 and 
$2,557,819 in 1993 and 1992, respectively.  The decrease was 
primarily attributable to an increase in notes receivables on 
nonaccrual status in 1993 compared to 1992.

Item 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
- ------   -------------------------------------------

The financial statements of the Registrant are set forth in 
Item 14.

Item 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING
- ------   -----------------------------------------------------------
         AND FINANCIAL DISCLOSURE
         -----------------------

Registrant has reported no disagreements with its accountants 
on matters of accounting principles or practices or financial 
statement disclosure.

                               PART III

Item 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
- -------  --------------------------------------------------

As a partnership, the Registrant has no directors or 
executive officers.  Technology Funding Ltd., a California 
limited partnership ("TFL") and Technology Funding Inc., a 
California corporation ("TFI") and wholly-owned subsidiary of 
TFL, are the General Partners of the Partnership.  TFI is the 
Managing General Partner.  Information concerning the 
ownership of TFL and the business experience of the key 
officers of TFI and the partners of TFL is incorporated by 
reference from the sections entitled "Management of the 
Partnership - The General Partners" and "Management of the 
Partnership - Key Personnel of the Managing General Partners" 
in the Prospectus, which are incorporated herein by 
reference.  Changes in this information that have occurred 
since the date of the Prospectus are included in the 
Technology Funding Medical Partners I, L.P. Prospectus, as 
modified by Cumulative Supplement No. 4 dated January 4, 
1995, forming a part of the May 3, 1993 Pre-Effective 
Amendment No. 3 to the Form N-2 Registration Statement 
No. 33-54002 dated October 30, 1992 which is incorporated 
herein by reference.

Item 11. EXECUTIVE COMPENSATION
- -------  ----------------------

As a partnership, the Registrant has no officers or 
directors. In 1994, the Partnership incurred management fees 
of $272,615.  The management fees are designed to compensate 
the General Partners for General Partner Overhead incurred in 
performing management duties for the Partnership through 
December 31, 1994.  General Partner Overhead includes rent, 
utilities, and certain salaries and benefits paid by the 
General Partners.

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND 
- -------  ---------------------------------------------------
         MANAGEMENT
         ----------

Not applicable.  No Limited Partner beneficially holds more 
than 5% of the aggregate number of Units held by all Limited 
Partners, and neither the General Partners nor any of their 
officers, directors or partners own any Units.  The General 
Partners control the affairs of the Partnership pursuant to 
the Partnership Agreement.

Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
- -------  ----------------------------------------------

The Registrant has engaged in no transactions with the 
General Partners or their officers and partners other than as 
described above, in the notes to the financial statements, or 
in the Prospectus.

                               PART IV

Item 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON 
- -------  -------------------------------------------------------
         FORM 8-K
         --------
(a)  List of Documents filed as part of this Annual Report 
on Form 10-K

(1)  Financial Statements - the following financial 
statements are filed as a part of this Report:

Independent Auditors' Report
Balance Sheets as of December 31, 1994
 and 1993
Statements of Operations for the years ended
 December 31, 1994, 1993 and 1992
Statements of Partners' Capital for 
 the years ended December 31, 1994, 1993
 and 1992
Statements of Cash Flows for the years
 ended December 31, 1994, 1993 and 1992
Notes to Financial Statements

(2)  Financial Statements Schedules

All schedules have been omitted because they are 
not applicable or the required information is 
included in the financial statements or the notes 
thereto.

(3)  Exhibits

Registrant's Amended and Restated Limited 
Partnership Agreement (incorporated by reference 
to Exhibit A to Registrant's Prospectus dated 
March 16, 1989 included in Registration Statement 
No. 33-26190 filed pursuant to Rule 424(b) of the 
General Rules and Regulations under the Securities 
Act of 1933).

(b)  Reports on Form 8-K

No reports on Form 8-K were filed by the Registrant 
during the year ended December 31, 1994.

(c)  Financial Data Schedule for the year ended and as of 
December 31, 1994 (Exhibit 27).
<PAGE>

                         INDEPENDENT AUDITORS' REPORT
                         ----------------------------



The Partners
Technology Funding Secured Investors III,
An Income And Growth Partnership, L.P.:


We have audited the accompanying balance sheets of Technology Funding 
Secured Investors III, An Income And Growth Partnership, L.P. (a 
California limited partnership) as of December 31, 1994 and 1993, and 
the related statements of operations, partners' capital, and cash 
flows for each of the years in the three-year period ended 
December 31, 1994.  These financial statements are the responsibility 
of the Partnership's management.  Our responsibility is to express an 
opinion on these financial statements based on our audits.

We conducted our audits in accordance with generally accepted auditing 
standards.  Those standards require that we plan and perform the audit 
to obtain reasonable assurance about whether the financial statements 
are free of material misstatement.  An audit includes examining, on a 
test basis, evidence supporting the amounts and disclosures in the 
financial statements.  Our procedures included confirmation of loans 
by correspondence with the individual borrowing companies and a 
physical examination of securities held as of December 31, 1994 and 
1993.  An audit also includes assessing the accounting principles used 
and significant estimates made by management, as well as evaluating 
the overall financial statement presentation.  We believe that our 
audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present 
fairly, in all material respects, the financial position of Technology 
Funding Secured Investors III, An Income And Growth Partnership, L.P., 
as of December 31, 1994 and 1993, and the results of its operations 
and its cash flows for each of the years in the three-year period 
ended December 31, 1994 in conformity with generally accepted 
accounting principles.

As explained in Notes 1, 5 and 6, the financial statements include 
investments of $10,061,584 and $14,368,587 (84% and 80% of partners' 
capital) as of December 31, 1994 and 1993, respectively, whose values, 
in certain circumstances, have been estimated by the Managing General 
Partner in the absence of readily ascertainable market values.  We 
have reviewed the procedures used by the Managing General Partner in 
arriving at its estimate of value of such investments and have 
inspected underlying documentation, and, in the circumstances, we 
believe the procedures are reasonable and the documentation 
appropriate.  However, because of the inherent uncertainty of 
valuation, those estimated values may differ significantly from the 
values that would have been used had a ready market for the 
investments existed, and the difference could be material.





San Francisco, California                        KPMG Peat Marwick LLP
March 17, 1995

<PAGE>

BALANCE SHEETS
- --------------

<TABLE>
<CAPTION>

                                                  December 31,
                                       -------------------------------
                                            1994               1993
                                            ----               ----
<S>                                    <C>                <C>
ASSETS

Investments:
 Secured notes receivable, net 
  (cost basis of $12,385,060 and 
  $16,262,392 in 1994 and 1993, 
  respectively)                       $ 8,569,060         12,585,392
 Equity investments (cost basis
  of $4,070,004 and $2,079,194 in
  1994 and 1993, respectively)          1,492,524          1,783,195
 Other (cost basis of $650,000
  in 1993)                                     --            650,000
                                       ----------         ----------

     Total investments                 10,061,584         15,018,587

Cash and cash equivalents               1,921,850          3,069,767

Due from affiliated partnerships               --             39,125

Due from related parties                       --              8,768

Other assets                               75,113              4,830
                                       ----------         ----------

     Total                            $12,058,547         18,141,077
                                       ==========         ==========

LIABILITIES AND PARTNER'S CAPITAL

Accounts payable and accrued expenses $   100,005            121,139

Due to affiliated partnerships              1,054                 --

Due to related parties                      7,376                 --

Other liabilities                          32,527             20,659
                                       ----------         ----------

     Total liabilities                    140,962            141,798

Commitments (Notes 3 and 8)

Partners' capital:
 Limited Partners
  (Units outstanding of 399,977 
  in both 1994 and 1993)               18,419,721         22,044,323
 General Partners                        (108,656)           (72,045)
 Net unrealized fair value decrease
  from cost:
  Secured notes receivable             (3,816,000)        (3,677,000)
  Equity investments                   (2,577,480)          (295,999)
                                       ----------         ----------

  Total partners' capital              11,917,585         17,999,279
                                       ----------         ----------

    Total                             $12,058,547         18,141,077
                                       ==========         ==========
</TABLE>

See accompanying notes to financial statements.

<PAGE>

STATEMENTS OF OPERATIONS 
- ------------------------


<TABLE>
<CAPTION>
                                    For the Years Ended December 31,
                                -------------------------------------
                                    1994        1993         1992
                                    ----        ----         ----
<S>                            <C>           <C>           <C>
          
Income:
 Secured notes receivable
  interest                     $ 1,376,736    1,185,647     2,557,819
 Short-term investment interest    118,585      147,704       200,857
 Other income                       16,873       33,672        47,539
                                 ---------    ---------     ---------
  Total income                   1,512,194    1,367,023     2,806,215

Costs and expenses:
 Management fees                   272,615      374,130       513,659
 Amortization of organizational
  costs                              3,000        9,000         9,000
 Other investment expenses         132,220           --            --
 Operating expenses:
  Lending operations and
   investment management           220,552      428,277       563,516
  Administrative and investor
   services                        280,705      326,591       472,210
  Computer services                 77,113       94,518       150,404
  Professional fees                 51,248       89,530        82,434
  Expenses absorbed by
   General Partners                (95,227)    (268,515)      (77,452)
                                 ---------    ---------     ---------
   
   Total operating expenses        534,391      670,401     1,191,112
                                 ---------    ---------     ---------

 Total costs and expenses          942,226    1,053,531     1,713,771
                                 ---------    ---------     ---------

Net operating income               569,968      313,492     1,092,444

 Net realized gain from sale of
  equity investments               425,431      476,335       127,957
 Realized losses from
  investment write-downs        (4,082,445)  (1,902,799)     (276,284)
                                 ---------    ---------     ---------

Net realized (loss) income      (3,087,046)  (1,112,972)      944,117

 Change in net unrealized 
  fair value:
   Secured notes receivable       (139,000)    (118,000)   (2,945,926)
   Equity investments           (2,281,481)     209,851    (1,506,486)
                                 ---------    ---------     ---------

Net loss                       $(5,507,527)  (1,021,121)   (3,508,295)
                                 =========    =========     =========

Net realized (loss) income
   per Unit                    $        (8)          (3)            2
                                 =========    =========     =========
</TABLE>
See accompanying notes to financial statements.



<PAGE>

STATEMENTS OF PARTNERS' CAPITAL 
- ------------------------------


<TABLE>
<CAPTION>
For the years ended December 31, 1994, 1993 and 1992:

                                                        Net Unrealized Fair Value
                                                      Increase (Decrease) From Cost
                                                      -----------------------------
                                Limited      General     Equity     Secured Notes
                               Partners     Partners   Investments   Receivable    Total
                               --------     --------   -----------   ----------    -----
<S>                           <C>            <C>       <C>          <C>         <C>
Partners' capital,
 December 31, 1991            $28,232,685         --    1,000,636     (613,074) 28,620,247

Distributions                  (3,609,680)   (36,461)          --           --  (3,646,141)

Net realized income               944,117         --           --           --     944,117

Change in net unrealized fair
 value:
  Equity investments                   --         --   (1,506,486)          --  (1,506,486)
  Secured notes receivable             --         --           --   (2,945,926) (2,945,926)
                               ----------    -------    ---------    ---------  ----------
Partners' capital, 
 December 31, 1992             25,567,122    (36,461)    (505,850)  (3,559,000) 21,465,811

Distributions                  (2,420,957)   (24,454)          --           --  (2,445,411)

Net realized loss              (1,101,842)   (11,130)          --           --  (1,112,972)

Change in net unrealized fair 
 value:
  Equity investments                   --         --      209,851           --     209,851
  Secured notes receivable             --         --           --     (118,000)   (118,000)
                               ----------    -------    ---------    ---------  ----------

Partners' capital,
 December 31, 1993             22,044,323    (72,045)    (295,999)  (3,677,000) 17,999,279

Distributions                    (568,425)    (5,742)          --           --    (574,167)

Net realized loss              (3,056,177)   (30,869)          --           --  (3,087,046)

Change in net unrealized fair 
 value:
  Equity investments                   --         --   (2,281,481)          --  (2,281,481)
  Secured notes receivable             --         --           --     (139,000)   (139,000)
                               ----------    -------    ---------    ---------  ----------

Partners' capital,
 December 31, 1994            $18,419,721   (108,656)  (2,577,480)  (3,816,000) 11,917,585
                               ==========    =======    =========    =========  ==========

</TABLE>
See accompanying notes to financial statements.



<PAGE>

STATEMENTS OF CASH FLOWS
- ------------------------

<TABLE>
<CAPTION>
                                   For the Years Ended December 31,
                                  ------------------------------------
                                       1994       1993         1992
                                       ----       ----         ----

<S>                               <C>          <C>         <C>
Cash flows from operations:
 Interest received                $   920,099   1,048,331    2,487,752
 Other income received                 16,873      33,672       47,539
 Cash paid to vendors                (504,228)   (404,293)    (340,907)
 Cash paid to related parties        (688,844) (1,115,010)  (1,293,639)
 Cash received from/(paid to)
  affiliated partnerships              40,179     (55,985)     457,634
 Reimbursement of collection
  expenses received from a 
  portfolio company                   187,441          --           --
                                    ---------   ---------    ---------
    Net cash (used) provided 
     by operations                    (28,480)   (493,285)   1,358,379
                                    ---------   ---------   ----------

Cash flows from investing
 activities:
 Secured notes receivable issued   (4,075,046) (9,089,745) (19,545,596)
 Repayments of secured notes 
  receivable                        3,147,801   8,133,335   15,044,254
 Proceeds from sale of 
  equity investments                  430,181   1,852,576      296,011
 Purchase of equity investments       (48,206)    (21,101)    (200,000)
 Purchase of other investments             --    (650,000)          --
                                    ---------   ---------   ----------
Net cash (used) provided by
 investing activities                (545,270)    225,065   (4,405,331)
                                    ---------   ---------   ----------

Cash flows from financing 
  activities:
 Distributions to Limited and 
  General Partners                   (574,167) (3,265,499)  (3,645,600)
                                    ---------   ---------   ----------

  Net cash used by financing
   activities                        (574,167) (3,265,499)  (3,645,600)
                                    ---------   ---------   ----------

Net decrease in cash and 
 cash equivalents                  (1,147,917) (3,533,719)  (6,692,552)

Cash and cash equivalents at 
 beginning of year                  3,069,767   6,603,486   13,296,038
                                    ---------   ---------   ----------

Cash and cash equivalents at 
 end of year                      $ 1,921,850   3,069,767    6,603,486
                                    =========   =========   ==========

</TABLE>
See accompanying notes to financial statements.

<PAGE>

STATEMENTS OF CASH FLOWS (continued)
- -----------------------------------
<TABLE>
<CAPTION>
                                      For the Years Ended December 31,
                                   ------------------------------------
                                     1994          1993        1992
                                     ----          ----        ----
<S>                               <C>          <C>         <C>
Reconciliation of net loss
 to net cash (used) provided by
 operations:

Net loss                          $(5,507,527) (1,021,121) (3,508,295)

Adjustments to reconcile net 
 loss to net cash (used)
 provided by operations:
 Amortization of organizational
  costs                                 3,000       9,000       9,000
 Amortization of discount 
   on secured notes receivable        (12,110)    (72,082)   (182,294)
 Net realized gain from sale of
  equity investments                 (425,431)   (476,335)   (127,957)
 Realized losses from investment
  write-downs                       4,082,445   1,902,799     276,284
 Change in net unrealized 
  fair value:
   Equity investments               2,281,481    (209,851)  1,506,486
   Secured notes receivable           139,000     118,000   2,945,926

Changes in:
  Accrued interest on secured and
   convertible notes receivable      (563,112)   (212,938)    (88,630)
  Accounts payable and accrued
   expenses                           (21,134)    (29,114)     (4,469)
  Due to/from related parties          16,144    (459,825)     66,714
  Due to/from affiliated 
   partnerships                        40,179     (55,985)    457,634
  Other assets                        (73,283)      9,322      (7,834)
  Other, net                           11,868       4,845      15,814
                                    ---------   ---------   ---------

Net cash (used) provided
  by operations                   $   (28,480)   (493,285)  1,358,379
                                   ==========   =========   =========

Non-cash investing activities:

Additions to equity investments   $   100,556       6,667     126,929
                                   ==========   =========   =========

Conversion of secured notes
 receivable and interest to
 equity investments               $ 2,270,450   2,374,746     785,700
                                   ==========   =========   =========

Conversion of other investments
 to secured notes receivable      $   650,000          --          --
                                   ==========   =========   =========

Non-cash exercise of warrants     $    (1,122)         --     105,290
                                   ==========   =========   =========

</TABLE>
See accompanying notes to financial statements.

<PAGE>

NOTES TO FINANCIAL STATEMENTS
- -----------------------------

1.     Summary of Significant Accounting Policies
       ------------------------------------------

Organization
- ------------

Technology Funding Secured Investors III, An Income and Growth 
Partnership, L.P., (the "Partnership") is a limited partnership 
organized under the laws of the State of California on 
December 9, 1988.  From December 9, 1988 through March 15, 1989, the 
Partnership was inactive.  The registration statement of the 
Partnership was filed with the Securities and Exchange Commission and 
became effective on March 16, 1989.  The purpose of the Partnership is 
to provide loans secured by equipment and other assets to new and 
developing companies and to acquire, hold, sell, trade, exchange or 
otherwise dispose of warrants and/or capital stock acquired by the 
Partnership in conjunction with these loans.  The General Partners are 
Technology Funding Ltd. ("TFL") and Technology Funding Inc. ("TFI"), a 
wholly-owned subsidiary of TFL.  TFI is the Managing General Partner.  
A wholly-owned subsidiary of TFI, Technology Funding Securities 
Corporation ("TFSC"), was the dealer-manager for the offering.

The Partnership commenced selling units of limited partnership interest 
("Units") on April 13, 1989.  On May 2, 1989 the minimum number of 
Units required to commence Partnership operations (12,000) had been 
sold.  The Partnership completed the offering of the Units of limited 
partnership interest on March 15, 1991.  The offering terminated with 
399,977 Units sold.  The Partnership Agreement provides that the 
Partnership will continue until December 31, 1998, unless further 
extended for up to two additional two-year periods from such date if 
the General Partners so determine or the Partnership may be dissolved 
sooner.

Cash and Cash Equivalents
- -------------------------

Cash and cash equivalents are principally comprised of cash invested in 
demand accounts, money market instruments and commercial paper and are 
stated at cost plus accrued interest.  The Partnership considers all 
money market and short-term investments with an original maturity of 
three months or less to be cash equivalents.

Organizational Costs
- --------------------

Included in other assets are organizational costs of $45,000, which are 
amortized over 60 months using the straight-line method.

Provision for Income Taxes
- --------------------------

No provision for income taxes has been made by the Partnership, as the 
Partnership is not directly subject to taxation.  The partners are to 
report their respective shares of Partnership income or loss on their 
individual tax returns.

The accompanying financial statements are prepared using generally 
accepted accounting principles which may not equate to tax accounting, 
however, the difference in the total book and tax basis as of December 
31, 1994 is not material.

Net Realized Income (Loss) Per Unit
- -----------------------------------

Net realized income (loss) per Unit is calculated by dividing the 
number of Units outstanding (399,977) at December 31, 1994, 1993 and 
1992 into total net realized income (loss) allocated to the Limited 
Partners.  The General Partners contributed an amount equal to 0.1% of 
total Limited Partner capital contributions and did not receive any 
Partnership Units.

Investments:
- -----------

The Partnership's method of accounting for investments, in accordance 
with generally accepted accounting principles, is the fair value basis 
used for investment companies.  The fair value of Partnership 
investments is their initial cost basis with changes as noted below:

     Secured Notes Receivable, Net
     -----------------------------

The secured notes receivable portfolio includes accrued interest less 
the discount related to warrants and the allowance for loan losses.  
The portfolio approximates fair value through inclusion of an allowance 
for loan losses.  Allowance for loan losses is reviewed quarterly by 
the Managing General Partner and is adjusted to a level deemed adequate 
to cover possible losses inherent in notes and unfunded commitments.  
Notes receivable are placed on nonaccrual status when, in the opinion 
of the Managing General Partner, the future collectibility of interest 
or principal is in doubt.

In conjunction with the secured notes granted, the Partnership has 
received warrants to purchase certain shares of capital stock of the 
borrowing company.  The cost basis of the warrants and the resulting 
discount has been estimated by the Managing General Partner to be 1% of 
the principal balance of the original notes made to the borrowing 
company.  The discount is amortized to interest income on a straight-
line basis over the term of the loan.  These warrants are included in 
the equity investment portfolio.

Nonrefundable fees received in connection with loan fundings are 
deferred and amortized to interest income over the contractual life of 
the loan using the effective interest method or the straight-line 
method if it is not materially different.  Direct loan origination 
costs mainly consist of third-party costs and generally are reimbursed 
by portfolio companies.

     Equity Investments
     ------------------

The fair value for publicly-traded equity investments (marketable 
equity securities) is based upon the five-day average closing sales 
price or bid/ask price that is available on a national securities 
exchange or over-the-counter market. Certain publicly-traded equity 
investments may not be marketable due to selling restrictions.  For 
publicly-traded equity investments with selling restrictions, an 
illiquidity discount of 25% is applied when determining the fair value.  
Sales of equity investments are recorded on the trade date.  The basis 
on which cost is determined in computing realized gains or losses is 
generally specific identification.

Other equity investments, which are not publicly traded, are generally 
valued utilizing pricing obtained from the most recent round of third 
party financings.  Valuation is determined quarterly by the Managing 
General Partner.  Included in equity investments are convertible or 
subordinated notes receivable as repayment of these notes may occur 
through conversion into equity investments.

Equity investments with temporary changes in fair value result in 
increases or decreases to the unrealized fair value of equity 
investments.  The cost basis does not change.  In the case of an other 
than temporary decline in value below cost basis, an appropriate 
reduction in the cost basis is recognized as a realized loss.  
Adjustments to fair value basis are reflected as "Change in net 
unrealized fair value of equity investments."  Cost basis adjustments 
are reflected as "Realized losses from investment write-downs" on the 
Statements of Operations.

Non-cash Exercise of Warrants
- -----------------------------

Periodically, the Partnership may acquire stock through the non-cash 
exercise of warrants.  During 1994 and 1992, realized (losses) gains 
resulting from the non-cash exercise of warrants totaled $(1,122) and 
$105,290, respectively.  No such event occurred in 1993.  These amounts 
are included in net realized gain from sale of equity investments.

Distributions
- -------------

Distributions made to the Limited Partners are made among such partners 
in proportion to their respective capital accounts to the total of all 
capital accounts of the group.  Distributions are made generally 
quarterly within 90 days following the end of each previous calendar 
quarter unless an eligible partner elects a monthly distribution.  
Unnegotiated distribution checks, if any, after a reasonable amount of 
time, are recorded as other liabilities on the Balance Sheets.

Reclassifications
- -----------------

Certain 1993 and 1992 balance have been reclassified to conform with 
the 1994 financial statement presentation.


2.     Change in Net Unrealized Fair Value of Equity Investments
       ---------------------------------------------------------

In accordance with the accounting policy as stated in Note 1, the 
Statements of Operations include a line item entitled "Change in net 
unrealized fair value of equity investments."  The table below 
discloses details of the changes:

<TABLE>
<CAPTION>

                                 For the Years Ended December 31,
                            ------------------------------------------
                                  1994         1993          1992
                                  ----         ----          ----
<S>                           <C>            <C>         <C>

(Decrease) increase in fair
 value from cost of marketable 
 equity securities            $    (9,163)     37,000       299,035
Decrease in fair 
 value from cost of non-
 marketable equity securities  (2,568,317)   (332,999)     (804,885)
                                ---------     -------     ---------
 Net unrealized fair value
  decrease from
  cost at end of year          (2,577,480)   (295,999)     (505,850)
 Net unrealized fair value
  (decrease) increase from
  cost at beginning of year      (295,999)   (505,850)    1,000,636
                                ---------     -------     ---------
 Change in net unrealized 
  fair value of equity
  investments                 $(2,281,481)    209,851    (1,506,486)
                                =========     =======     =========

</TABLE>


3.     Related Party Transactions
       --------------------------

Related party costs are included in costs and expenses shown on the 
Statements of Operations.  For the years ended December 31, 1994, 1993 
and 1992, related party costs were as follows:

<TABLE>
<CAPTION>

                                 1994           1993           1992
                                 ----           ----           ----
<S>                           <C>             <C>            <C>

Management fees               $272,615        374,130        513,659
Amortization of
 organizational costs            3,000          9,000          9,000
Reimbursable operating
 expenses:
  Lending operations and
   investment management       234,262        229,194        444,543
  Administrative and 
   investor services           216,225        225,858        329,250
  Computer services             77,113         94,518        150,353
  Expenses absorbed by
   General Partners            (95,227)      (268,515)       (77,452)

</TABLE>
Management fees compensate the General Partners solely for General 
Partner Overhead (as defined in the Partnership Agreement) incurred in 
supervising the operation, management, and progress of Partnership 
loans to borrowing companies and its portfolio of warrants and capital 
stock of borrowing companies, as well as for the general administration 
of the Partnership.  For the first and second years after the 
commencement date, management fees are incurred and payable at 3% of 
total limited partners' capital contributions.  Thereafter, the 
management fee is equal to the greater of one-half of one percent of 
the Partnership's assets under management or $2,500 each quarter. 

Currently, management fees are accrued and are only paid to the extent 
that the aggregate amount of all proceeds (including those from 
warrants exercised without cash) received by the Partnership from the 
sale or other disposition of borrowing company equity securities plus 
the aggregate fair market value of any equity interest distributed to 
the partners exceeds the total management fees payable.  All management 
fees had been paid at December 31, 1994 compared to $7,671 of 
management fees payable at December 31, 1993 as this limitation was in 
effect.

The Partnership reimburses the General Partners and affiliates for 
operating costs incurred in connection with the business of the 
Partnership.  Reimbursable operating costs include costs other than 
Organizational and Offering Expenses and General Partner Overhead (as 
defined in the Partnership Agreement).  At December 31, 1994, due to 
related parties totaled $7,376 for reimbursable operating expenses, 
compared to due from related parties of $16,439 at December 31, 1993.  
As discussed in the Partnership Agreement, the Partnership may not pay 
or reimburse the General Partners for expenses that aggregate more than 
2% of total Limited Partner capital contributions in any of the first 
five years of Partnership operations, and 1% thereafter.  For purposes 
of this limitation, the Partnership's operating year begins each May 
1st.  Beginning May 1, 1994, the limitation was calculated using 1% of 
total Limited Partner capital contributions.  Operating costs of 
$95,227, $268,515, and $77,452 for the years ended December 31, 1994, 
1993 and 1992, respectively, were absorbed by the General Partners. 

During 1994, the Partnership was reimbursed $187,441 by a portfolio 
company for legal, consulting, and other external costs incurred in the 
defense of the Partnership's secured note rights through bankruptcy 
court.  Of the amount reimbursed, approximately $130,000 was incurred 
in prior periods during which the operating expense limitation applied.  
Similarly, another reimbursement of approximately $28,000 was received 
during the year, of which approximately $24,000 was expensed during the 
prior fiscal year when the operating expense limitation applied.  The 
$130,000 and $24,000 recoveries were recorded as reductions to lending 
operations and investment management expense, and the amount absorbed 
by General Partners was reduced by equivalent amounts.

Under the terms of a computer support agreement, the Partnership 
recognized charges from Technology Administrative Management, a 
division of TFL, for its share of computer support costs.  These 
amounts are included in computer services expense.

Within the normal course of business, the Partnership participates with 
affiliated partnerships in secured notes receivable granted to non-
affiliated borrowing companies by affiliated partnerships which are 
also managed by the General Partners.  At December 31, 1994, due to 
affiliated partnerships on such participations were $1,054 compared to 
a due from of $39,125 at December 31, 1993.  The amounts were paid to 
and received from such affiliated partnerships by the Partnership 
immediately following the respective year ends.  The Partnership may 
also reparticipate such secured notes receivable amongst affiliated 
partnerships to meet business needs.

TFL currently has a sublease rental agreement with a Partnership 
portfolio company in the computers and computer equipment industry.

4.     Allocation of Profits and Losses
       --------------------------------

Net realized profit and loss of the Partnership are allocated based on 
the beginning of year partners' capital balances as follows:

     (a)  Profits:

(i)  first, to those partners with deficit capital account 
balances until deficits have been eliminated;

(ii) second, to the partners as necessary to offset the net 
realized loss previously allocated under (b)(ii) below 
and sales commissions;

(iii)third, 99% to the Limited Partners and 1% to the General 
Partners until the Limited Partners have been allocated 
cumulative net realized profit or other income which 
would, if distributed, result in a cumulative, 
compounded annual return to the Limited Partners of 8% 
of their adjusted capital contributions;

(iv) fourth, 75% to the Limited Partners as a group in 
proportion to the number of Units held, 5% to the 
Limited Partners in proportion to the Unit months of 
each Limited Partner, and 20% to the General Partners.  
Unit months are the number of half months a Unit would 
be outstanding if held from the date the original holder 
of such Unit was deemed admitted into the Partnership 
until the termination of the offering of Units.

Allocations to the Limited Partners are made in the 
proportion that the number of Units held by each Limited 
Partner multiplied by the number of Unit months for those 
Units represents of the total number of Units multiplied by 
the total number of Unit months of all Units.  In no event 
are the General Partners allocated less than 1% of the net 
realized profit of the Partnership.

     (b)  Losses:

(i)  first, to the partners as necessary to offset the net 
realized profit previously allocated to the partners 
under (a)(iv) above; then

(ii) 99% to the Limited Partners and 1% to the General 
Partners.

Losses in excess of Limited Partner capital accounts will be 
allocated to the General Partners.

5.     Equity Investments
       ------------------

At December 31, 1994 and 1993, equity investments consisted of:



<TABLE>
<CAPTION>
                                                  December 31, 1994          December 31, 1993
                                                  -----------------          -----------------
                    Investment                     Cost        Fair          Cost         Fair
Industry/Company       Date      Position          Basis       Value         Basis       Value
- ----------------    ----------   --------          -----       -----         -----       -----
<S>                 <C>          <C>               <C>         <C>         <C>         <C>
WARRANTS:

Biotechnology
- -------------
Biocircuits         01/91        20,000 Common
 Corporation                     shares at $2.00;
                                 expiring 01/96    $      0           0       4,000      41,000
Hybridon, Inc.      03/91        7,142 Common
                                 shares at $3.50;
                                 expiring 03/97       2,500      32,139       2,500      67,583

Computers and Computer Equipment
- --------------------------------
Alantec             08/91        79,221 Common
                                 shares at $.66;
                                 expiring 08/98          --          --       3,500     114,078
Komag, Inc.         12/91        238 Common shares
                                 at $21.61; exercised
                                 08/94                   --          --       1,250       1,250
MARCorp             05/92        1,595,745 Series B
                                 Preferred shares
                                 at $1.00; expiring
                                 05/97                    0           0           0           0
MARCorp             06/93        566,667 Series B
                                 Preferred shares 
                                 at $.75; expiring
                                 06/98                    0           0           0           0
MARCorp             08/93        500,000 Series B
                                 Preferred shares at
                                 $.75; expiring 08/98     0           0           0           0
MARCorp             03/94        125,000 Series B
                                 Preferred shares at
                                 $.75; expiring 03/99     0           0          --          --
Pinnacle Systems,   05/90        2,083 Common
 Inc.                            shares at $8.00; 
                                 expiring 05/95       2,500      14,164       2,500       2,500

Computer Software and Systems
- -----------------------------
Datalogix           01/92        35,575 Common
 International,                  shares at $1.87;
 Inc.                            expiring 01/97      20,000      20,000      20,000      20,000
Logisticon, Inc.    08/89        21,739 Common
                                 shares at $.23;
                                 expired 08/94           --          --           0           0
Logisticon, Inc.    02/90        16,304 Common
                                 shares at $.23;
                                 expired 08/94           --          --           0           0
Molecular           10/90        6,111 Common
 Simulations, Inc.               shares at
 (formerly Polygen               $18.00;
 Corporation)                    expiring 10/95           0           0      10,000      10,000
Wasatch Education   04/93        705,971 Common
 Systems                         shares at $.50;
 Corporation                     expiring 04/98           0           0           0     264,739
Wasatch Education   07/93        33,333 Common
 Systems                         shares at $.50;
 Corporation                     expiring 07/98       6,667           0       6,667      12,500
Wasatch Education   02/94        366,667 Common
 Systems                         shares at $.50;
 Corporation                     expiring 02/99       3,333           0          --          --
Wright Express      08/90        114,521 Common
 Corporation                     shares at $.87;
                                 expiring 08/95          --          --      20,000      20,000

Industrial Business Automation
- ------------------------------
Cyclean, Inc.       03/91        44,589 Common
                                 shares at $3.10;
                                 expiring 04/01       7,500           0       7,500       7,500
Cyclean, Inc.       07/92        20,967 Common
                                 shares at $3.10;
                                 expiring 07/97       2,500           0       2,500       2,500
Cyclean, Inc.       07/92        53,130 Common
                                 shares at $3.10;
                                 expiring 07/02       1,176           0       1,176       1,176
Cyclean, Inc.       09/94        8,065 Common
                                 shares at $3.10;
                                 expiring 03/99           0           0          --          --
Cyclean, Inc.       09/94        9,464 Common
                                 shares at $4.00;
                                 expiring 03/99           0           0          --          --
ElectroScan         12/91        22,177 Common
 Corporation                     shares at $3.10;
                                 expiring 12/96           0           0           0           0

Medical
- -------
Loredan             04/91        150,000 Common
 BioMedical,                     shares at $.60;
 Inc.                            expiring 04/96          --          --           0           0
Loredan             05/92        62,500 Common
 BioMedical,                     shares at $.60;
 Inc.                            expiring 05/97           0           0           0           0
Loredan             12/92        166,667 Common
 BioMedical,                     shares at $.30;
 Inc.                            expiring 12/97           0           0           0           0
Microgon, Inc.      10/90        125,000 Common
                                 shares at $.60;
                                 expiring 10/95           0           0           0           0
Microgon, Inc.      09/91        29,167 Common
                                 shares at $.60;
                                 expiring 09/96           0           0           0           0
Microgon, Inc.      06/92        125,000 Common
                                 shares at $.60;
                                 expiring 06/97           0           0           0           0
National Pain       03/92        45,920 Common
 Institute                       shares at $8.33;
                                 expiring 03/97          --          --      30,000      30,000
Resonex, Inc.       08/90        187,500 Common
                                 shares at $1.00;
                                 expiring 08/95          --          --           0           0
Resonex, Inc.       09/90        46,875 Common
                                 shares at $1.00;
                                 expiring 09/95          --          --           0           0
Resonex, Inc.       10/91        600,000 Common
                                 shares at $1.00;
                                 expiring 10/96          --          --           0           0
Resonex, Inc.       10/92        228,000 Common
                                 shares at $1.00;
                                 expiring 10/97          --          --           0           0
Resonex, Inc.       04/93        680,000 Common
                                 shares at $1.00;
                                 expiring 01/98          --          --           0           0

Microelectronics
- ----------------
Celeritek           05/89        4,523 Common 
                                 shares at $7.50;
                                 exercised 05/94         --          --       2,164       2,164

Telecommunications
- ------------------
All Post, Inc.      08/93        17,574 Common
                                 shares at $.79;
                                 expiring 08/95          --          --           0           0
Integrated Network  06/91        11,765 Common
 Corporation                     shares at $17.00;
                                 expiring 06/96      20,000     100,002      20,000      20,000
Primary Access      10/90        33,333 Common
 Corporation                     shares at $2.25;
                                 expiring 10/95       6,000       6,000       6,000       6,000
                                                     ------     -------     -------     -------

Total warrants                                       72,176     172,305     139,757     622,990
                                                     ------     -------     -------     -------

STOCKS:

Computers and Computer Equipment
- --------------------------------
MTI Technology      04/94        20,927 Common
 Corporation                     shares             188,343      74,563          --          --

Industrial/Business Automation
- ------------------------------
Cyclean, Inc.       09/94        36,042 Series D
                                 Preferred
                                 shares             100,556     100,556          --          --

Medical
- -------
Allegiant 
 Physicians         08/94        63,000 Common
 Services, Inc.                  shares              35,000     127,953          --          --
Resonex Holding     02/94        22,804 Common
 Corporation                     shares           1,682,507           0          --          --

Microelectronics
- ----------------
Celeritek, Inc.     05/94        4,523 Common
                                 shares              36,087      36,087          --          --

Retail/Consumer Products
- ------------------------
GP Publications,    03/92        200,000 Common
 Inc.                            shares             200,000     200,000     200,000     200,000
GP Publications,    06/93        435,310 Common
 Inc.                            shares             435,310     435,310     435,310     435,310
S-TRON              05/93        Subordinated
                                 note (1), $390,000 
                                 principal amount   392,015     130,316     390,000     203,148
S-TRON              05/93        390,000 Common
                                 shares                   0           0           0           0
S-TRON              05/93        897,000 
                                 Series 1
                                 Preferred shares   295,740           0     295,740           0
S-TRON              05/93        2,753,356 
                                 Series 2
                                 Preferred shares   618,387     201,551     618,387     321,747

Telecommunications
- ------------------
All Post, Inc.      10/94        17,574 Common
                                 shares              13,883      13,883          --          --
                                                  ---------   ---------   ---------   ---------

  Total stocks                                    3,997,828   1,320,219   1,939,437   1,160,205
                                                  ---------   ---------   ---------   ---------

  Total equity investments                       $4,070,004   1,492,524   2,079,194   1,783,195
                                                  =========   =========   =========   =========

- --  No investment held at end of period.
0   Investment active with a carrying value or fair value of zero.
(1) Subordinated note includes accrued interest.  The subordinated note interest rate was 6%.
</TABLE>



Marketable Equity Securities
- ----------------------------

At December 31, 1994 and 1993, marketable equity securities had 
aggregate costs of $225,843 and $5,250, respectively, and aggregate 
market values of $216,680 and $42,250, respectively.  The net 
unrealized (loss) gain at December 31, 1994 and 1993 included gross 
gains of $104,617 and $37,000, respectively.

Alantec
- -------

In February 1994, the company completed its initial public offering at 
an offering price of $13.00 per share.  The Partnership exercised its 
common warrants and then sold the resulting common shares in the 
offering for $430,053 and realized a gain on the sale of $426,553.

All Post, Inc.
- --------------

In October 1994, the Partnership cash exercised its warrants to 
purchase 17,574 common shares.

Biocircuits, Inc.
- -----------------

Based on the Managing General Partner's opinion, there has been an 
other than temporary decline in the market value of the Partnership's 
investment.  Accordingly, the Partnership had written off its warrant 
investment of $4,000 and recorded a decrease in fair value of $41,000 
at December 31, 1994.

Celeritek, Inc.
- ---------------

In May 1994, the Partnership exercised its warrants to purchase 4,523 
common shares.  The recorded cost basis and fair value of $36,087 
included the cash exercise price of $33,923 at $7.50 per share 
(adjusted during 1994) and the warrant cost basis of $2,164.

Cyclean, Inc.
- -------------

In September 1994, the Partnership restructured its secured notes 
previously issued to Cyclean, Inc.  In exchange for an extension of 
the maturity date and certain interest rate changes, the Partnership 
received a warrant for 8,065 shares of common stock exercisable at 
$3.10 per share expiring March 1999, a second warrant for 9,464 shares 
of common stock exercisable at $4.00 per share expiring March 1999, 
and 36,042 shares of Series D Preferred stock.  The Partnership 
recorded the cost basis and fair value at $100,556 for the preferred 
stock received, and recorded a decrease in fair value of $11,176 for 
the Partnership's existing warrants based on the Managing General 
Partner's judgment.  In addition, the expiration dates for the 
Partnership's existing Cyclean, Inc. common stock warrants were 
extended as part of the restructuring.

Integrated Network Corporation
- ------------------------------

In addition to the Partnership's right to exercise its warrant for 
common stocks, the Partnership has an option to sell its common share 
warrant back to the company for $100,002.  Accordingly, this amount is 
recorded as the fair value at December 31, 1994.

Komag, Inc.
- -----------

In August 1994, the Partnership exercised its warrants without cash 
and received 5 common shares.  Immediately after the warrant exercise, 
these shares were sold for total proceeds of $128 resulting in a 
realized loss of $1,122.

MTI Technology Corporation
- --------------------------

System Industries, Inc. (System), a notes receivable portfolio company 
of the partnership, filed for protection under Chapter 11 of the 
United States Bankruptcy Code in late 1993.  In April 1994, 
substantially all the assets of System were acquired by MTI.  As 
consideration for the amount due, the Partnership received a new 
secured note in MTI, cash from certain MTI common shares sold, and 
received an additional 20,927 shares of MTI common stock.  A cost 
basis of $188,343 was assigned to the common shares received (based on 
market value at time of issuance), and an unrealized fair value 
decrease of $113,780 was recorded to reflect the market price for 
these unrestricted, publicly-traded shares at December 31, 1994.

Pinnacle Systems, Inc.
- ----------------------

In November 1994, Pinnacle Systems, Inc. completed its initial public 
offering at $8 per share.  The Partnership recorded an increase in 
fair value of $11,664 for its existing warrant investment at December 
31, 1994 to reflect the publicly-traded market value for the common 
stock.

Allegiant Physicians Services, Inc./National Pain Institute, Inc.
- -----------------------------------------------------------------

In August 1994, the Partnership received 63,000 common shares of 
Allegiant Physicians Services, Inc. (Allegiant) in exchange for its 
45,920 common share warrants in National Pain Institute, Inc. (NPI) as 
a result of Allegiant's acquisition of NPI.  The Partnership recorded 
an unrealized fair value increase of $92,953 to reflect the market 
price for these unrestricted shares at December 31, 1994.

Resonex, Inc./Resonex Holding Corporation
- -----------------------------------------

In February 1994 the Partnership, together with two affiliated 
partnerships, assigned their Resonex, Inc. note holdings to Resonex 
Holding Corporation ("RHC"), a new company wholly-owned by the 
Partnership and the affiliated partnerships.  RHC foreclosed on the 
assets of Resonex, Inc.  The partnerships' ownership of RHC is in 
proportion to their respective Resonex, Inc. loan balances.  The 
Partnership received 22,804 common shares of RHC in exchange for $400 
cash and its share of Resonex, Inc. secured notes totaling $2,082,107.  
During 1994, a realized loss of $400,000 was recorded based on the 
Managing General Partner's opinion, reducing the investment book value 
to $1,682,507 with an estimated fair value of zero at September 30, 
1994 pending the results of management actions being taken.  The 
Managing General Partner's intention is to maximize the net realizable 
value on this investment.

S-TRON
- ------

In late 1994, based on the Managing General Partner's estimate, the 
fair value of the Partnership's investment had declined.  Accordingly, 
the Partnership recorded a change in fair value decrease of $195,043 
on its existing investments at December 31, 1994.

Wasatch Education Systems Corporation
- -------------------------------------

In February 1994, the Partnership increased the borrowing capacity on 
an accounts receivable line of credit to the company and received 
366,667 common share warrants.  The Partnership recorded a change in 
fair value decrease of $280,572 for the company's restricted warrants 
based on the publicly-traded market price of this investment at 
December 31, 1994.

In 1993, based on a June 1993 financing round and the relatively low 
level of common stock trading to set a market price, the fair value 
for the company's common stock was estimated to be $1.00 per share.  
Since there has not been a recent round of financing, the publicly-
traded market price is used to value warrants at December 31, 1994.

Other Equity Investments
- ------------------------

In 1994, the Partnership realized losses of $30,000 from equity 
investment write-offs for two portfolio companies not previously 
discussed above due to discontinued operations or an other than 
temporary decline in value.

All other equity investments not specifically discussed above are 
privately held and no public market for the sale of these securities 
exists.

6.     Secured Notes Receivable, Net
       -----------------------------

At December 31, 1994 and 1993, secured notes receivable consisted of:

<TABLE>
<CAPTION>
                                                1994        1993
                                                ----        ----
<S>                                         <C>           <C>
Secured notes receivable                    $12,069,120   16,290,272
Accrued interest                                514,632      295,700
Unamortized discount                           (198,692)    (323,580)
                                             ----------   ----------
   Secured notes receivable, net 
    (cost basis)                             12,385,060   16,262,392

   Allowance for loan losses                 (3,816,000)  (3,677,000)
                                             ----------   ----------

   Secured notes receivable, net
    (fair value)                            $ 8,569,060   12,585,392
                                             ==========   ==========

</TABLE>
The 1994 notes were primarily from three portfolio companies in the 
computers and computer equipment, computer software and systems, and 
telecommunications industries.  The remaining loans were from 
approximately five companies in a variety of industries.  All notes 
are secured by specific assets of the borrowing company.  Interest 
rates on secured notes receivable at December 31, 1994 ranged from 10% 
to 21%.

During 1994, approximately $190,000 of accrued interest was converted 
to equity investments and approximately $154,000 was written off as a 
result of notes being placed on nonaccrual status.

Changes in the allowance for loan losses were as follows:

<TABLE>
<CAPTION>

                                                 1994        1993
                                                 ----        ----

<S>                                         <C>           <C>

Balance, beginning of year                  $ 3,677,000    3,559,000
                                              ---------    ---------

Provision for loan losses                     3,633,632      969,776

Secured notes receivable write-downs:
   Computers and computer equipment          (3,465,000)    (575,000)
   Medical                                      (29,632)          --
   Retail/consumer products                          --     (276,776)
                                              ---------    ---------
     Total write-offs                        (3,494,632)    (851,776)
                                              ---------    ---------

Change in net unrealized fair value of
 secured notes receivable                       139,000      118,000
                                              ---------    ---------

Balance, end of year                        $ 3,816,000    3,677,000
                                              =========    =========

</TABLE>

The provision for loan losses is generally comprised of realized 
losses, net of recognized recoveries, and a change in net unrealized 
fair value based upon the level of loan loss reserves deemed adequate 
by the Managing General Partner at the respective year ends.

Notes receivable with a total cost basis of $6,867,764 and $10,078,126 
were on nonaccrual status at December 31, 1994 and 1993, respectively, 
due to uncertainties in the financial condition of certain portfolio 
companies.  The decrease in nonaccrual notes was primarily due to 
secured note write-downs.  The Managing General Partner continues to 
monitor the progress of these companies and intends to manage these 
investments to maximize the Partnership's net realizable value.  The 
fair value at December 31, 1994 is based on the Managing General 
Partner's estimate of collectibility of these notes.

The allowance for loan losses is adjusted based upon changes to the 
portfolio size and risk profile.  Although the allowance for loan 
losses is established by evaluating individual debtor repayment 
ability, the allowance represents the Managing General Partner's 
assessment of the portfolio as a whole.  

During 1993, the Partnership invested $650,000 in a certificate of 
deposit (CD) with a financial institution which was recorded as an 
other investment.  The CD was pledged as collateral for a loan between 
the financial institution and a portfolio company in the computers and 
computer equipment industry.  In August 1994, a decision was made by 
the Managing General Partner to allow the financial institution to 
draw on the CD for principal repayment and the secured note was 
assigned to the Partnership.


The scheduled principal repayments remaining are:
<TABLE>
<CAPTION>

          Year Ending         Principal
          December 31,        Repayments
          -----------         ----------
          <S>                 <C>
             1995             $ 6,366,606
             1996               4,742,976
             1997                 375,000
             1998                      --
             1999                 584,538
                               ----------

                              $12,069,120
                               ==========

</TABLE>

Secured notes receivable which are due on demand are included as 
principal repayments for the year ending December 31, 1995.  In 
addition, the Managing General Partner may at times need to 
restructure notes by either extending maturity dates or converting 
notes to equity investments to increase the ultimate collectibility of 
investments to the Partnership.

7.     Cash and Cash Equivalents
       -------------------------

At December 31, 1994 and 1993, cash and cash equivalents consisted of:

<TABLE>
<CAPTION>

                                                 1994          1993
                                                 ----          ----

<S>                                         <C>             <C>
Demand and brokerage accounts               $    7,802         28,440
Money-market accounts                        1,914,048      3,041,327
                                             ---------      ---------


     Total                                  $1,921,850      3,069,767
                                             =========      =========

</TABLE>

8.     Commitments
       -----------

The Partnership is a party to financial instruments with off-balance-
sheet risk in the normal course of its business.  Generally, these 
instruments are equipment financing commitments or accounts receivable 
lines of credit that are outstanding but not currently fully utilized 
by a borrowing company.  As they do not represent current outstanding 
balances, these unfunded commitments are properly not recognized in 
the financial statements.  At December 31, 1994, the Partnership had 
unfunded commitments of $484,000 related to accounts receivable lines 
of credit.

The Partnership uses the same credit policies in making these 
commitments and conditional obligations as it does for on-balance-
sheet instruments.  Commitments to extend financing are agreements to 
lend to a company as long as there are no violations of any conditions 
established in the contract.  The credit lines generally have fixed 
termination dates or other termination clauses.  Since many of the 
commitments are expected to expire without being fully drawn upon, the 
total commitment amounts do not necessarily represent future cash 
requirements.  All commitments funded require collateral specified in 
the agreements.

9.      Litigation and Other Investment Expenses
        ----------------------------------------

Other investment expenses reflect the participated cost of legal 
action between a third party and a portfolio company in the 
retail/consumer products industry.  The Partnership participated in 
investments to the portfolio company with an affiliated partnership.  
The Managing General Partner is subject to indemnification for such 
costs pursuant to the Partnership Agreement.  Accordingly, these 
expenses are excluded from the calculation of operating expense 
limitation.  At December 31, 1994, the Partnership had accrued 
expenses of $47,000 for future costs to defend the case.

In late 1992, the portfolio company and the affiliated partnership 
filed a lawsuit against the third party claiming that the affiliated 
partnership had the right to take possession of collateral, the price 
paid was fair and did not interfere with the third party's legal 
rights.  The third party filed a countersuit claiming otherwise and is 
seeking relief for $2.6 million.  An estimate of possible loss cannot 
be determined at this time; however, the Managing General Partner 
believes the outcome will not have a material adverse effect on 
partners' capital.  Accordingly, no amounts have been provided in the 
accompanying financial statements for any possible negative outcome in 
this matter.



<PAGE>
                              SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities 
Exchange Act of 1934, the Registrant has duly caused this Report to be 
signed on its behalf by the undersigned, thereunto duly authorized.

                         TECHNOLOGY FUNDING SECURED INVESTORS III,
                         AN INCOME AND GROWTH PARTNERSHIP, L.P.

                         By:  TECHNOLOGY FUNDING INC.
                              Managing General Partner




Date:  March 17, 1995    By:       /s/Frank R. Pope
                              --------------------------------------
                                   Frank R. Pope
                                   Executive Vice President and Chief
                                   Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, 
this Report has been signed below by the following persons on behalf 
of the Registrant and in the capacities and on the dates indicated:

          Signature           Capacity                   Date
          ---------           --------                   ----

   /s/Charles R. Kokesh       President, Chief       March 17, 1995
- ------------------------      Executive Officer
Charles R. Kokesh             and Chairman of
                              Technology Funding Inc.
                              and Managing General
                              Partner of Technology
                              Funding Ltd.

   /s/Frank R. Pope           Executive Vice         March 17, 1995
- ------------------------      President, Chief
Frank R. Pope                 Financial Officer,
                              Secretary and a 
                              Director of Technology
                              Funding Inc. and a 
                              General Partner of
                              Technology Funding Ltd.

   /s/Gregory T. George       Group Vice President   March 17, 1995
- --------------------------    of Technology Funding
Gregory T. George             Inc. and a General
                              Partner of Technology
                              Funding Ltd.


The above represents a majority of the Board of Directors of 
Technology Funding Inc. and a majority of the General Partners of 
Technology Funding Ltd.


<TABLE> <S> <C>

<ARTICLE>6
<LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION 
EXTRACTED FROM THE FORM 10-K AS OF DECEMBER 31, 1994 AND IS QUALIFIED 
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
<MULTIPLIER>1
       
<FISCAL-YEAR-END>             DEC-31-1994
<PERIOD-START>                JAN-01-1994
<PERIOD-END>                  DEC-31-1994
<PERIOD-TYPE>                        YEAR
<INVESTMENTS-AT-COST>          16,455,064
<INVESTMENTS-AT-VALUE>         10,061,584
<RECEIVABLES>                           0
<ASSETS-OTHER>                     75,113
<OTHER-ITEMS-ASSETS>            1,921,850
<TOTAL-ASSETS>                 12,058,547
<PAYABLE-FOR-SECURITIES>                0
<SENIOR-LONG-TERM-DEBT>                 0
<OTHER-ITEMS-LIABILITIES>         140,962
<TOTAL-LIABILITIES>               140,962
<SENIOR-EQUITY>                         0
<PAID-IN-CAPITAL-COMMON>       18,311,065
<SHARES-COMMON-STOCK>             399,977
<SHARES-COMMON-PRIOR>             399,977
<ACCUMULATED-NII-CURRENT>               0
<OVERDISTRIBUTION-NII>                  0
<ACCUMULATED-NET-GAINS>                 0
<OVERDISTRIBUTION-GAINS>                0
<ACCUM-APPREC-OR-DEPREC>       (6,393,480)
<NET-ASSETS>                   11,917,585
<DIVIDEND-INCOME>                       0
<INTEREST-INCOME>               1,495,321
<OTHER-INCOME>                     16,873
<EXPENSES-NET>                    942,226 
<NET-INVESTMENT-INCOME>           569,968
<REALIZED-GAINS-CURRENT>       (3,657,014)
<APPREC-INCREASE-CURRENT>      (2,420,481)
<NET-CHANGE-FROM-OPS>          (5,507,527)
<EQUALIZATION>                          0
<DISTRIBUTIONS-OF-INCOME>        (574,167)
<DISTRIBUTIONS-OF-GAINS>                0
<DISTRIBUTIONS-OTHER>                   0
<NUMBER-OF-SHARES-SOLD>                 0
<NUMBER-OF-SHARES-REDEEMED>             0
<SHARES-REINVESTED>                     0
<NET-CHANGE-IN-ASSETS>         (6,081,694)
<ACCUMULATED-NII-PRIOR>                 0
<ACCUMULATED-GAINS-PRIOR>               0
<OVERDISTRIB-NII-PRIOR>                 0
<OVERDIST-NET-GAINS-PRIOR>              0
<GROSS-ADVISORY-FEES>             272,615
<INTEREST-EXPENSE>                      0
<GROSS-EXPENSE>                 1,050,148
<AVERAGE-NET-ASSETS>           14,958,432
<PER-SHARE-NAV-BEGIN>                  55
<PER-SHARE-NII>                        (8)
<PER-SHARE-GAIN-APPREC>                 0 <F1>
<PER-SHARE-DIVIDEND>                    0
<PER-SHARE-DISTRIBUTIONS>              (1)
<RETURNS-OF-CAPITAL>                    0
<PER-SHARE-NAV-END>                    46
<EXPENSE-RATIO>                       .06
<AVG-DEBT-OUTSTANDING>                  0
<AVG-DEBT-PER-SHARE>                    0
<FN>
<F1>
A zero value is used since the change in net unrealized fair value is 
not allocated to General Partners and Limited Partners as it is not 
taxable.  Only taxable gains or losses are allocated in accordance 
with the Partnership Agreement.
</FN>

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission